U.S., Feb. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07435103) titled 'Xenon Therapy for Children With Autism Spectrum Disorder' on Feb. 05.
Brief Summary: This study aims to evaluate the efficacy and safety of inhaled xenon for the treatment of children with autism spectrum disorder (ASD). The primary objective is to determine whether short-term inhalational xenon therapy can improve social functioning in children with ASD, as measured by changes in the Social Responsiveness Scale (SRS). Safety and tolerability of xenon inhalation in the pediatric population will also be assessed.
In this randomized, placebo-controlled trial, participants will receive either inhaled xenon or a placebo gas (medical ai...